Onsdag 28 Oktober | 17:19:21 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Genovis Q2 2025 - Undramatic report but recent developments are case supporting

2025-08-13 11:47:00

Redeye updates its view on Genovis' following a Q2 2025 report falling slightly short of our estimates and the recently expanded licese agreement with Thermo Fischer which we find supportive to the long-term case.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/